Clinical Trial Update: Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating diquafosol tetrasodium ophthalmic solution 2% versus placebo for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Diquafosol Tetrasodium Ophthalmic Solution, 2% (diquafosol tetrasodium ophthalmic solution)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED